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CBA/N mice, a  mutant CBA subline,  are of particular interest for studies of 
the  requirements  for  B-cell  activation  since  they  harbor  an  X-linked  B-cell 
defect (1). The defect is characterized by low levels of circulating IgM, reduced 
numbers  of splenic  B  cells,  and  a  total  failure  of existing  B  cells  to  mount 
immune  responses  to  certain  thymic-independent  antigens,  e.g.,  haptenated 
Ficoll derivatives (2-5). Those B cells present in CBA/N spleens are character- 
ized by a generally increased density of cell surface IgM (6). In addition, CBA/N 
mice have an abnormally high ratio of mu chain to delta chain homolog on their 
B-cell surfaces  (7).  In  this  respect,  the  Ig receptor density of CBAJN B  cells 
appears to resemble the Ig density on B cells of neonatal and very young mice 
(8).  Since  the  usual  progression  from  mu  chain  to  delta  chain  homolog 
expression on these cell surfaces is greatly delayed in CBAJN mice and in the 
hybrid  male  progeny of CBAJN females,  Scher et al.  have  proposed that  the 
CBA/N defect might represent an arrest in B-cell maturational development (6, 
7). 
CBA/N  mice  and  their  affected hybrid  male  offspring  are  also  profoundly 
sensitive to selective B-cell blockade (9).  Several other animal  models exist in 
which the  injection  of a  haptenated  thymic-independent  antigen  can  block a 
subsequent response to a  thymic-dependent antigen  bearing the same hapten 
(10-14).  The marked blockade susceptibility of CBAJN mice is transmitted  via 
the X  chromosome,  since all the male hybrid offspring of CBAJN females are 
affected.  The  hybrid  female  offspring  are  not  affected  at  dosage  levels  of 
haptenated  polysaccharide up to three orders of magnitude  above those which 
can yield virtually total  hapten-specific blockade both in  the  CBAJN parents 
and in the hybrid males (9). 
The  present  study  was  designed  to  explore  the  cellular  and  molecular 
conditions necessary for production of this selective blockade. Several hapten- 
ated  polysaccharide  agents  were examined  for their  relative  effectiveness in 
producing blockade, and a  wide range of efficiencies was observed. In addition, 
the effect of prior immune status on blockade susceptibility was investigated. 
The  generation  of hapten-specific  immune  memory  to  a  thymic-dependent 
antigen  virtually  abolishes  the  inherent  susceptibility  of  CBA/N  mice  to 
selective hapten-polysaccharide-mediated blockade. Moreover, the imposition of 
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blockade on secretory B ceils in defective mice appears to have little if any effect 
on their subsequent development of B memory cell populations. 
Materials and Methods 
Animals.  CBAJN,  C3H/HeN,  CBA/CaHN-T6,  and F,  hybrid mice derived from these inbred 
strains were obtained from the  Small Animal Production Section of the National Institutes of 
Health, Bethesda, Md. The F, hybrids were prepared by breeding CBA/N female mice with C3H/ 
HeN or with CBA/CaHN-T6 males. All mice used were between 6 and 15 wk of age. The CBA/N 
mice (formerly designated CBAIHN) are a mutant subline of CBA mice, and their origin has been 
previously described (1). 
Immunogens.  Keyhole limpet hemocyanin (KLH)' was purchased from Schwarz/Mann, Div. 
Becton,  Dickinson  &  Co.,  Orangeburg,  N.  Y.  Ficoll,  a  synthetic  polymer  of sucrose  with  an 
average  mol  wt  of 400,000,  was  obtained from  Pharmacia  Fine Chemicals,  Piscataway,  N.  J. 
Pneumococcal  pelysaccharide,  type  III  (SIII),  was  a  giR  from  Dr.  Phillip J.  Baker,  National 
Institute  of  Allergy  and  Infectious  Diseases.  The  enlarged  hapten,  N-(2,4-dinitrophenyl)-B- 
alanylglycylglycine, (DNP), was synthesized as its tert-butyloxycarbenyl hydrazide as previously 
described  (15).  This reagent was converted to its reactive acyl  azide  (16)  and coupled to N-(2- 
aminoethyl)-carbamylmethylated Ficoll (AECM-FicoII) as described by Inman (17). The pH of the 
reaction mixture was adjusted to  ~- 8.5  with 1 N  KOH  after addition of the hapten azide.  The 
degree of conjugation was calculated from dry weight and optical absorbance measurements (17) 
to yield  DNPsy-AECM~5-Ficoll  ,  or  simply,  "DNP59-FicolI."  The  subscript refers  to  the  average 
number of haptenic groups coupled to 400,000 daltons of the original Ficoll. 
A portion of the naturally occurring carboxyl functions of pneumococcal polysaccharide,  SIll, 
was  converted to  N-(2-aminoethyl)  amide  groups,  and  this  modified  polysaccharide  was  then 
conjugated with the reactive DNP azide as previously described (9).  Spectrophotometric analysis 
(17)  revealed  52  DNP  groups  bound  to  400,000  daltons  of polysaccharide.  This  product  was 
designated DNP52-SIII. 
DNP22-KLH  was  prepared  as  described by Inman,  et  al.  (16).  Here,  subscripts refer to  the 
number of haptenic  groups  per  100,000  daltons of original KLH.  Ficoll,  conjugated  with N-e- 
dinitrophenyl-h-lysine (with no tripeptide), was a gift from Dr. Philip R. B. McMaster, Bureau of 
Biologics. It was prepared by a cyanuric chloride coupling procedure which McMaster et al. have 
published (18).  For convenience, this smaller-hapten derivative is designated as dnp~,~-Ficoll.  All 
antigens and blocking agents were injected intraperitoneally (i.p.). 
Hapten-Conjugated  Erythrocytes.  Sheep erythrocytes (SRC) were obtained in sterile Alsever's 
solution from the National Institutes of Health Animal Production Unit. SRC, pooled from six to 
eight sheep, were conjugated with the tripeptide-enlarged DNP hapten under optimal conditions 
according to the method of Inman et al. (16). 
Cell  Suspensions.  Spleens  were  obtained  from  mice  at  sacrifice,  minced  in  cold  Hanks' 
balanced  salt  solution,  and  cell  aggregates  were  disrupted  by  aspiration  through  a  Pasteur 
pipette.  The cell suspensions were passed through a  thin layer of glass wool to remove fibrous 
connective tissue,  washed in Hanks' balanced salt solution,  and counted on a  model  B  Coulter 
counter (Coulter Electronics Inc., Hialeah, Fla.). 
Plaque-Forming  Cell Assays.  Suspensions of spleen cells from individual mice were assayed 
for  DNP-reactive  antibody-secreting  cells  by  a  modification  of  the  Jerne  hemolytic  plaque 
technique as previously reported  (19).  All recorded plaque-forming cell (PFC) values have been 
corrected for coexisting direct PFC background against SRC.  Data have been expressed as the 
mean log~o PFC/spleen  -~  SEM.  Student's t  test was employed to evaluate differences between 
groups  of mice.  Differences  were  considered  to  be  significant  when P  values of <_  0.05  were 
obtained. 
Results 
The Effect of Varying Hapten Derivatization Levels on the Efficacy of Specific 
Hapten-Polysaccharide-Mediated  Blockade.  AECMTs-Ficoll  was  conjugated 
Abbreviations  used in this paper:  AECM,  Aminoethylcarbamylmethyl; dnp, the 2,4-dinitro- 
phenyl  hapten;  DNP,  the  tripeptide-enlarged  hapten,  N-(2,4-dinitrophenyl)-B-alanylglycylgly- 
cine; i.p.,  intraperitoneally; KLH,  keyhole limpet hemocyanin; PFC,  plaque-forming cells; SIII, 
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Dosage of Blockading Agent 
Fro.  1.  Dose-response  relationships  in  haptenated  polysaccharide-mediated  blockade. 
CBA/N mice were immunized with 50/~g of DNP~.,-KLH i.p. 2 h after receiving varying i.p. 
dosages of haptenated polysaccharide blocking agents. Each dose-response curve represents 
the results for a  single experiment; each point represents the geometric mean of the direct 
splenic DNP-reactive  PFC  response for 5  mice.  The results have been normalized by as- 
signing a  value of 100% to the unsuppressed control group for each experiment to allow for 
comparisons between experiments. 
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with the tripeptide-enlarged  DNP hapten at each of three derivatization levels, 
and these preparations  were compared in dose-response experiments  for their 
capacity to produce hapten-polysaccharide-mediated  selective B-cell blockade. 
DNP~2-SIII  and  small  hapten  dnpE~-Ficoll  were  also  employed  in  order  to 
evaluate their blockade-invoking capacity. The data obtained are presented in 
Fig.  1. The normalized dose-response curves show the relative capacity of these 
haptenated polysaccharide agents to block the 4th-day direct PFC response to 
DNP22-KLH in CBA/N mice. 
DNP59-Ficoll was the  most effective blockading agent.  It  produced roughly 
90% suppression of 4th-day direct PFC after injection of as little as 100 pg. Due 
to individual  mouse variation,  the first statistically significant  blockade with 
DNPsg-Ficoll occurred at the 10-ng dosage level. This still amounted to a 5,000- 
fold net "signal  advantage"  per unit of weight over the  50  /~g of DNP22-KLH 
which  was  successfully blockaded.  As  previously  observed in  normal  mouse 
strains by Desaymard and Waldmann (20), and Desaymard et al.  (21), reducing 
the derivatization level of DNP-polymers profoundly reduced their efficiency in 
producing  hapten-specific  blockade.  Also,  dn~5-Ficoll  was particularly  ineffi- 
cient as a  blockading agent.  This implies that  the tripeptide-enlarged  form of 
the DNP hapten confers a more stable interaction with Ig receptors on target B 
cells, thus augmenting the blockade phenomenon.  DNP52-SIII, a  linear saccha- 
ride  polymer,  was intermediate  between DNP59-Ficoll and  DNP~o-Ficoll in its 
blockade-inducing  effectiveness.  This  indicates  that  blockade is  not produced 
exclusively by multi-branched  polymers such as the haptenated  Ficoll deriva- 
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TABLE I 
Failure of AECM-Ficoll to Produce Blockade of the 4th Day Direct PFC Response to 
DNP,,..,-KLH in CBA/N x  C3H/HeN F~ Mice 
Group num-  Blocking agents 
ber* and sex 
Immunizing antigen 
Mean log direct DNP-reactive 
PFC/spleen ±  SE (geometric mean) 
Experiment A  Experiment B 
I. Male  AECM1~o-Ficoll  -  ND§  2.39  -+ 0.05 
(244) 
II. Male  -  50/zg DNP:2-KLH  3.61  -+ 0.11  3.19 ±  0.19 
(4,107)  (1,548) 
III. Male  AECMl~o-Ficoll  50/~g DNP22-KLH  3.78  _-. 0.2511  3.02  ±  0.131[ 
(6,047)  (1,046) 
IV. Female  AECM12o-Ficoll  -  ND  3.54  ±  0.03 
(3,496) 
V. Female  -  50  ~g DNP2o.-KLH  4.47  _+ 0.14  4.11  ±  0.14 
(29,279)  (12,983) 
VI. Female  AECM~zo-Ficoll  50 ~g DNP~...-KLH  4.33  ±  0.41¶  4.25  ±  0.07** 
(21,222)  (17,787) 
* Four or five mice per group. 
S 500/~g per mouse in Experiment A  and 1 mg per mouse in Experiment B, always at -  1 h. 
§ ND, not determined. 
[J Does not differ significantly from group II of the corresponding experiment;  in both instances 
P  ->0.20. 
¶  Does not differ significantly from group V; P  -> 0.30. 
** Does not differ significantly from group V; P  -> 0.10. 
Attempts to Blockade with Nonhaptenated  Ficoll.  In principle, blockade of 
B-cell  activation  by  DNP-Ficoll  might  occur  directly  through  its  specific 
interaction with surface Ig receptors. Or, DNP-Ficoll might block by interaction 
of  its  polysaccharide  moiety with some disparate  surface  component specialized 
to  receive  signals  from polysaccharides  or  other  polymeric entities.  According to 
this  latter  alternative,  Ig receptors  would serve  only to concentrate haptenated 
polysaccharide agents at the B-cell  surface, with the carrier  polysaccharide 
then delivering  the critical  signal to the defective  cell.  A preliminary test  of 
this  hypothesis was attempted by injecting  500/zg of  AECMi2o-Ficoll into  male 
or female hybrid mice just 1 h before immunizing them with 50 ~g of  DNP~2- 
KLH. Our findings  are presented in Table I. As often  occurs,  the 4th-day direct 
splenic  PFC responses to DNP22-KLH were substantially  higher in the female 
than in  the male hybrid mice in  both experiments A and B. However, AECM~2o- 
Ficoll  did not appreciably  reduce the response to DNP22-KLH in  male or  female 
hybrid mice in either  experiment. A further test  was carried  out in parental 
CBAJN  mice using  AECM~-Ficoll.  Here the preliminary  injection of this 
pelysaccharide  carrier  was given 4 h before  primary immunization with DNP22- 
KLH, and the AECMs3-Ficoll dosage was increased  to  2  mg (Table  II).  Although 
this  latter  dose represents a 200,000-fold  higher dosage of  Ficoll  than the 10 ng 
of  DNPs~-Ficoll which provided significant  blockade in Fig. i, no indication  of 
DNP-reactive PFC blockade could be detected. 
Further experiments were performed to test whether blockade  might be 
achieved by  employing both  the  hapten and  the Ficoll  carrier  signals  separately. 
The results  are provided in  Table Ill.  Free tripeptide-enlarged  DNP hapten was B.  MERCHANT,  H.  SNIPPE,  E.  F.  LlZZlO,  AND  J.  K.  INMAN  1759 
TABLE  II 
Failure of  AECMsa-Ficoll to Blockade the 4th Day Primary Immune Response  to 
DNP,,-KLH in CBA/N Mice 
Mean log direct 
Group  Blocking agent given at -4 h  Immunizing agent given at  DNP-reactive 
number*  time zero  PFC/spleen -+ SE 
(geometric mean) 
I.  -  50 ~g DNP2~-KLH  3.53  _+ 0.11 
(3,392) 
II,  2 mg AECMs3-Ficoll  50 ~tg DNP2~-KLH  3.57  ±  0.125 
(3,776) 
III.  1 mg AECMs3-Ficoll  50 ~g DNP~-KLH  3.48  -+ 0.155 
(3,050) 
IV.  500/~g AECMs3-Ficoll  50/~g DNP22-KLH  3.45  x  0.095 
(2,826) 
V.  250/~g AECMs3-Ficoll  50 ~g DNP.~.~-KLH  3.71  -+ 0.155 
(5,214) 
* Five mice per group. 
5 Does not differ significantly from group I; P  -  0.15. 
TABLE  III 
Chemical Attachment of  Hapten and Ficoll Required for Effective Blockade of  Direct 
PFC Response  to DNP.,.2-KLH in CBA/N Mice 
Blocking agents5  Mean log direct 
Group  DNP-reactive 
number*  PFC/spleen ± 
First  Second  SE (geometric 
mean) 
I.  -  -  4.50  ±  0.05 
(31,761) 
II.  -  10/~g DNPs~-Ficoll  3.32  _+ 0.07§ 
(2,089) 
III.  -  0.2 ml 10-3M DNP-hydrazidell  4.46  _+ 0.15¶ 
(28,969) 
IV.  100/~g AECMlzo-Ficoll  0.2 ml 10-4M DNP-hydrazide  4.53  _+ 0.03¶ 
(33,947) 
V.  1 mg AECMi2o-Ficoll  0.2 ml 10-3M DNP-hydrazide  4.63  -+ 0.13¶ 
(42,312) 
VI.  500/~g AECM~2o-Ficoll  10 ~g DNP59-Ficoll  3.00  _+ 0.12§ 
(991) 
* Five CBA/N female mice per group; all mice in all groups were immunized with 50 pg of DNP22- 
KLH, i.p. 
$ First and second blocking agents given 10 min apart at  ~2 h before immunization with DNP22- 
KLH. 
§ Differs significantly from group I; P  < 0.005. 
II The tripeptide-enlarged free hapten, N-(2,4-dinitrophenyl)-B-alanylglycylglycine Boc-hydrazide. 
¶ Does not differ significantly from group I; P  > 0.10. 
ineffective by itself in producing  hapten-specific  blockade.  Free  hapten  and  free 
Ficoll carrier  administered  concomitantly  were  also ineffective, even  when  each 
was  employed  at  a  100-fold  higher  concentration  (group  V)  than  its  effective 
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FTG.  2.  Sustained blockade in CBA/N mice given DNPsg-Ficoll at various junctures before 
immunization with DNP22-KLH,  Groups of 5 mice each received 10/~g of DNPbg-Ficoll i.p. 
at intervals of up to 14 days before i.p.  immunization with 50 Fg of DNP22-KLH.  Splenic 
DNP-reactive direct PFC were determined 4 days after DNP22-KLH  immunization.  Note 
that the degree of responsiveness is shown on a log scale, 
AECM12o-Ficoll  was ineffective in preventing the blockade imposed by only 10 
ftg of DNP~9-Ficoll. Accordingly, our findings indicate that the hapten and the 
carrier Ficoll must be chemically joined in order for hapten-speciflc blockade to 
OCCur. 
Temporal Requirements for Production of Specific Hapten-Ficoll-Mediated 
Blockade.  CBA/N mice were given 10 ~tg of DNP59-Ficoll at various intervals 
before immunization  with DNP22-KLH and their direct splenic PFC responses 
were measured 4 days after immunization.  The findings are depicted in Fig. 2 
which discloses that the blockade phenomenon is obtained at least as efficiently 
with DNP59-Ficoll delivered at -24 h as it is when the blockading agent is given 
at the time of immunization.  DNP59-Ficoll delivered at successively longer time 
intervals  before immunization  was progressively less effective in causing the 
blockade.  When delivered 14 days before DNP22-KLH immunization,  10  ~g of 
DNP59-Ficoll reduced  the  mean  4th-day  PFC  response  to  18%  of that  in  the 
control mice. Sufficient individual variation occurred in this group, however, so 
that the mean PFC reduction was not statistically significant.  Thus, it appears 
that some mice have largely escaped from blockade ai~r 14 days, but in others, 
the blockade remains relatively intact. 
In another  set of experiments,  DNP59-Ficoll was given at intervals ranging 
up to 48 h after immunization with 50 ~g of DNP22-KLH. The findings provided 
in Table IV, show that significant blockade was obtained in both CBAJN and F1 
male  hybrid  mice when  DNP59-Ficoll was given  up to  4  h  after  DNP~2-KLH 
immunization.  The  findings  also  suggest  that  hybrid  male  mice  may  be 
susceptible to blockade for a longer time after immunization than their CBAJN 
parents. B.  MERCHANT,  H.  SNIPPE,  E.  F.  LIZZIO,  AND  J.  K.  INMAN 
TABLE  IV 
Blockade of the Splenic PFC Response  to DNP.,..,-KLH by Post-Immunization 
Injection  of DNP59-Ficoll 
1761 
50 fig DNP22-  10 pg DNPs~- 
Group  KLH given at  Ficoll given 
number* 
time  at time 
Mean log direct DNP-reactive PFC/spleen -+ SE 
(Geometric Mean) [Percent of Control Response] 
CBA/N Females  CBA/N  ×  CBA/CaHN- 
T6 Males 
(h) 
I.  -  -  1.14  _+ 0.46  1.06  _+ 0.21 
(14)  (12) 
II.  0  -  3.36  ±  0.28 [100]  3.39  ±  0.17 [100] 
(2323)  (2473) 
III.  0  -2  2.53  ±  0.24 [14]$  2.21  _+ 0.42 [6]§ 
(341)  (164) 
IV.  0  +4  2.41  ±  0.23 [i1]~  2.83  ±  0.14 [27]§ 
(260)  (691) 
V.  0  +20  3.40  ±  0.13 [109111  2.67  _+ 0.49 [18]11 
(2549)  (469) 
VI.  0  +48  3.51  ±  0.12 [141]  3.25  ±  0.25 [73] 
(3282)  (1818) 
* Five mice per group; all injections were given i.p. 
$ Differs from group II; P  <  0.05. 
§ Differs from group II; P  <  0.025. 
II Does not differ significantly from group II of the corresponding experiment. 
TABLE V 
Failure of Prior Immunization with DNP22-KLH to Prepare CBA/N × C3H/HeN FI 
Mice for Responsiveness  to DNPs~-Ficoll 
Group hum-  First immunization  Second immunization 
ber* and sex  given on day 0  given on day 15 
Mean log DNP-reactive PFC/ 
spleen ±  SE$ (geometric mean) 
Direct PFC  Indirect PFC 
I.  Male  -  10 ~g DNP59-Ficoll  0.89 ±  0.36  1.13  ±  0.30 
(8)  (14) 
II.  Male  50 ~g DNP22-KLH  -  2.56 ±  0.65  2.71  _* 0.68 
(367)  (514) 
III.  Male  50 ~g DNP22-KLH  10 ~g DNP59-Ficoll  3.20 ±  0.13§  3.38 ±  0.09§ 
(1,607)  (2,448) 
IV.  Male  50 ~g DNP2~-KLH  50 ~g DNP22-KLH  3.81  ±  0.34  4.05 ±  0.29 
(6,572)  (11,431) 
V.  Female  -  10 ~g DNP59-Ficoll  4.86 ±  0.05  4.60 ±  0.05 
(73,958)  (40,075) 
VI.  Female  50 ~g DNP22-KLH  -  3.47 +  0.06  3.28 ±  0.03 
(2,994)  (1,936) 
VII.  Female  50 ~tg DNP22-KLH  10 ~g DNP59-Ficoll  4.37 ±  0.0~t  4.23 ±  0.0~1 
(23,815)  (16,991) 
VIII.  Female  50 ~g DNP22-KLH  50 fig DNP22-KLH  4.27 ±  0.28  4.46 ±  0.31 
(18,675)  (29,087) 
* Five mice per group. 
* All spleens assayed on day 19. 
§ Does not differ significantly from group II; P  >  0.10. 
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The Effects of Prior Immune Status on  the Capacity to Respond to DNP59- 
FicoU.  Although CBA/N mice and the hybrid male progeny of CBA/N females 
are unable to respond directly to DNP~-Ficoll, the existence of a specific hapten- 
Ficoll-mediated blockade implies a significant interaction of their B cells with 
this polysaccharide agent. Conceivably, B cells from DNP22-KLH-primed  CBA/ 
N mice might recognize the DNP~9-Ficoll signal as immunogenic. Thus, priming 
with DNP22-KLH might induce in defective mice some DNP-reactive memory B 
cells which could then undergo activation on subsequent encounter with DNP59- 
Ficoll. 
Male and female hybrid mice were immunized with DNP22-KLH and after 15 
days, were challenged either with DNP22-KLH or with DNPsg-Ficoll. The results 
of splenic PFC assays performed 4 days later are presented in Table V. Memory 
to DNP22-KLH had been generated in beth the male and female hybrid mice 
since their indirect PFC already exceeded their direct PFC on the 4th day post 
challenge (groups IV and VIII).  In hybrid female mice, challenge with DNP59- 
Ficoll caused both the direct and indirect PFC responses to be lower in DNP22- 
KLH-primed than in unprimed animals (compare group VII with group V). It is 
important to note that for hybrid females, the immunogenicity of DNP59-Ficoll 
is not neutralized by any circulating antibodies produced in response to prior 
immunization with DNP22-KLH (compare groups VI and VII). 
In male hybrid mice, the 4th-day direct and indirect PFC  responses after 
challenge with DNP59-Ficoll were both  modestly elevated; but,  the response 
levels did not differ significantly from the residual activity observed in control 
mice immunized 19  days earlier with  DNP22-KLH (compare group HI  with 
group II).  It is conceivable that some defective F1 male memory cells may be 
ultimately triggered by  subsequent contact with DNP59-Ficoll; however, the 
effect as currently observed falls far short of functional restoration. 
Attempts to Impose Hapten-Specific Blockade on Memory Cell Populations in 
CBA/N Mice.  Although generation of hapten-specific memory cell populations 
in defective mice conferred little if any capacity to respond directly to DNP59- 
Ficoll,  it was important to ascertain whether memory B cells, like precursor B 
cells, were susceptible to haptenated-Ficoll blockade. CBAJN mice were immu- 
nized with DNP22-KLH, and 10 days later they were challenged with the same 
antigen either with or without coexistent DNP59-Ficoll blockade. Our findings 
are recorded in Table VI. Again, indirect PFC outnumber direct PFC at 4 days 
after secondary challenge with DNP22-KLH (compare group HI with group II). 
DNP59-Ficoll could not produce significant reductions in either the direct or 
indirect PFC  responses of these memory cell-bearing defective CBA/N  mice. 
Thus, the generation of memory cell populations allows escape from blockade in 
these defective mice even though it  does  not confer any capacity for direct 
responsiveness to DNPs~-Ficoll. Whether or not circulating antibody elicited by 
prior encounter with DNP22-KLH could neutralize the blockading capacity of 
DNP59-Ficoll is uncertain. Such antibody does not neutralize the immunogenic- 
ity of DNP59-Ficoll in normal hybrid female mice (Table V). 
The Effect of DNP59-Ficoll-Mediated  Blockade on the Development of B-Cell 
Memory to DNP22-KLH.  Although DNP59-Ficoll virtually abrogates the 4th- 
day secretory B-cell response to DNP22-KLH, it was not clear whether DNP59- B.  MERCHANT,  H.  SNIPPE,  E.  F.  LIZZIO,  AND  J.  K.  INMAN 
TABLE  V~ 
Failure to Impose Blockade on Memory Cell Populations in CBA/N Mice 
1763 
Group  Primary immuni-  Blocking agent*  Secondary chal- 
number  zation  lenge* 
Mean log DNP-reactive  PFC/ 
spleen ±  SE§ (geometric 
mean) 
Direct  Indirect 
I.  DNP22-KLI~I  -  -  3.06 ±  0.11  2.37 ±  0.08 
(1157)  (236) 
II.  -  -  DNP2~-KLH  3.78 ±  0.12  2.94 ±  0.11 
(6020)  (866) 
III.  DNP2~-KLH  -  DNP22-KLH  3.32  -+  0.14  4.05  ±  0.03 
(2082)  (11,112) 
IV.  DNP2~-KLH  DNPss-Ficoll  DNP22-KLH  3.21  ±  0.16  3.82  ±  0.16 
(1619)¶  (6,545)¶ 
* 10 pg given 2 h before  secondary challenge. 
50/~g  on day I0. 
§ Assayed 4 days post  secondary challenge. Five mice in  each group. 
II  50 pg given at  time 0. 
¶ Does not  differ  from group III;  P -> 0.10. 
TABLE VII 
Failure of Blockade to Prevent Development of Memory Cell Populations in CBA/N 
Mice* 
Group  Primary block- 
number  ade$ 
Primary immuni-  Secondary block-  Secondary immu- 
zation  ade$  nization 
Mean log DNP-reactive PFC/spleen 
± SE§ (geometric mean) 
Direct  Indirect 
I.  -  DNP~2-KLH  4.11 ± 0.13  2,86 ± 0.15 
(12,763)  (732) 
II.  DNPs,-Ficoll  DNP2=-KLH  3.18 ± 0.07  3.06 ± 0.08 
(1,507)  (1,150) 
III  DNP22-KLH  DNP=,-KLH  3.34 ± 0.06  4.43 ± 0.05 
(2,204)  (27,180) 
IV.  DNPso-Ficoll  DNP2z-KLH  -  DNP,~-KLH  2.73 ± 0.13  4.30 -+ 0.141 
(538)  (10,830) 
V.  DNPbp-Ficoll  DNP,2-KLH  DNPw-Ficon  DNP2,-KLH  3.33 ± 0.22  4.36 ± 0.06¶ 
(2,157)  (23,031) 
* Tested by challenge at 30 days post primary blockade and immunization.  Five mice per group. 
$ 10 ~g DNPso-Ficoll given 1 h before immunization  with 50 ~.g DNP~s-KLH. 
§ Assayed 4 days aRer challenge. 
II Does not differ significantly from group HI; P <: 0.20. 
¶ Does not differ significantly from group IV; P <: 0.40. 
Ficoll  imposed an  absolute  blockade  of all  signals receivable by  B  cells from 
DNP22-KLH.  Accordingly,  CBA/N  mice  were  blockaded  with  DNP50-Ficoll 
before  an  initial  immunization  with  DNP22-KLH,  and  1  mo later  they  were 
challenged  with DNP22-KLH  either with or without secondary blockade.  Our 
findings are presented in Table VII. The defective CBA/N mice were blockaded 
on  day  0  and  challenged  on  day  30.  They  produced  indirect  PFC  responses 
almost  as  high  as  those  seen  in  control  mice  never  subjected  to  blockade 
(compare groups HI and IV).  In addition,  mice given a second blockade at the 
time of the 30  day challenge  were now also completely refractory to blockade 
(groups III vs.  V). Since we had previously shown that the effect of blockade is 1764  HAPTEN-SPECIFIC,  B-CELL  BLOCKADE  IN  CBA/N  MICE 
TABLE  VIII 
Failure of DNP59-Ficoll-Mediated Primary Blockade  to Affect the Secondary  Immune 
Response to DNP22-KLH in CBA/N Mice* 
Group num-  ,  Primary immuni-  Secondary block-  Secondary immu- 
Primary blockades 
her  zation§  ad~l  nization¶ 
Mean log DNP-reactive PFC/spleen *- 
SE** (geometric mean) 
Direct PFC  Indirect PFC 
I  -  DNP~2-KLH  3.75 *-  0.27  2.91 ±  0.11 
(5659)  (821) 
II.  -  DNP~-Ficoll  DNPs,-KLH  1.02 ±  0.44  0.47 -*  0.17 
(11)  (3) 
III.  -  DNP~2-KLH  -  DNPz2-KLH  3.20 +-  0.19  3.78 -+  0.00 
(1599)  (6051) 
IV  DNPs~.Ficon  DNP2~.KLH  -  DNP22-KLH  3.14 -* 0.19  3.82 ±  0.0955 
(1399)  (6648) 
V.  DNPsg-Ficoll  DNP22-KLH  DNP~D-Ficoll  DNF22-KLH  2.68 ± 0.11§§  3.50 -+.  0.I~[II 
(48,5)  (3182) 
* Tested by challenge at 8 days post primary blockade and immunization.  Five mice per group. 
$ 10 ~g DNPs0-Ficoll given on day 0. 
§ 50 ~g DNP~rKLH  on day 0 given 2 h after  the DNPs~-Ficoll blockade. 
[t 10 ~g DNPss-Ficoll given on day 8. 
50 ~g DNP~-KLH  on day 8 given 2 h aider  the second DNPss-Ficoll blockade. 
** Assayed 4 days aRer challenge. 
5$ Does not differ  significantly  from group III;  P < 0.40. 
§§ Differs  from group IV;  P < 0.05. 
]]I[  Does not differ  significantly  from group IV;  P < 0.10. 
reduced with time after exposure to DNP59-Ficoll (Fig.  2), it was important to 
recheck these findings at a time when memory cell populations might reasona- 
bly be expected to first  appear.  The  same experiment  was repeated,  but the 
DNP22-KLH challenge was given on day 8 rather than on day 30.  Our findings 
are presented in Table VIII.  Prior blockade with DNP59-Ficoll did not prevent 
the full development of memory B-cell populations in response to the concomi- 
tant  administration  of  DNP22-KLH  (groups  III  vs.  IV).  Efforts  to  produce 
secondary blockade at  day  8 again  failed to  significantly  reduce  the  indirect 
PFC response; the reduction of the direct PFC response, however, was margin- 
ally significant (groups IV vs. V). The overall effect stands in marked contrast 
to the effectiveness of DNP59-Ficoll in blockading the primary 4th-day secretory 
PFC response to DNP22-KLH. Apparently,  blockade of 4th-day secretory B-cell 
responses is of little predictive value for blockade of memory B-cell responsive- 
ness in CBAJN mice. 
Discussion 
The  B  Cell  as  the  Probable  Target  of Hapten-Polysaccharide-Mediated 
Blockade.  Our  current  findings  focus attention  on  B  cells  as  the  probable 
direct  targets  of the  X-linked  hapten-specific  blockade phenomenon.  Polysac- 
charides  carrying the tripeptide-enlarged  DNP hapten  were profoundly more 
efficient in  producing  blockade than  was another  polysaccharide  bearing the 
traditional small form of the dnp hapten (Fig. 1). This implies a critical role for 
Ig  receptors  in  the  blockade  phenomenon,  as  does  the  fact  that  increased 
haptenic  density  on  the  polysaccharide  agents  results  in  increased  blocking 
efficiency. Multiple Ig receptors probably must be cross-linked by haptenated 
polymer for blockade to ensue, since unjoined free hapten and free Ficoll carrier 
(each provided at 100-fold their usual conjugated dosage) were unable to produce B.  MERCHANT,  H.  SNIPPE,  E.  F.  LIZZIO,  AND  J.  K.  INMAN  1765 
blockade. In addition, DNP59-Ficoll  given at the usual 10 pg dosage level could 
not be functionally displaced by prior injection of a 50-fold excess of nonhapten- 
ated AECM12o-Ficoll (Table III). 
It has been proposed  (6) that the CBAJN B-cell defect in responsiveness to 
thymic-independent antigens  may be expressed at  any of three levels: (a)  a 
failure to bind thymic-independent antigens on B-cell surfaces, (b)  a failure to 
recognize thymic-independent antigens once they are bound on B-cell surfaces 
or (c) the absence of a unique B-cell subpopulation with the capacity to respond 
to  thymic-independent antigens.  Our  present  findings  indicate  that  CBAJN 
mice do have B cells which can recognize polysaccharide antigens; the recogni- 
tion  event, however, leads uniquely to  B-cell blockade rather than to  B-cell 
activation.  Thus,  it  is  still  possible  that  CBAJN  mice  may be  intrinsically 
unable to recognize haptenated polysaccharides in any way that would lead to 
secretory activation of their defective B cells. In general, our present findings 
favor the view that in unprimed CBA/N mice, a unique B-cell subpopulation is 
functionally missing. 
Possible Mechanisms of B-Cell Blockade.  The presence of a B-cell defect in 
CBA/N mice is well established (3, 4). If indeed macrophages and T cells are not 
directly involved in the intrinsic defect, then hypotheses which emphasize B- 
cell characteristics may be constructed in an attempt to explain the functional 
defect.  In  principle,  hapten-specific blockade of relevant B-cell  clones could 
occur through critical interactions between Ig receptors on such B cells and (a) 
monovalent haptens, (b) the Ficoll carrier molecule  2 (here a disparate or unique 
secondary receptor specific for polysaccharide would be required to initiate the 
blocking signal3),  (c) both of the above,  i.e.,  separate recognition of both the 
hapten and the carrier moieties by the same cell, or (d) multivalent hapten. In 
this latter case, no receptor specialized for recognition of the polymeric carrier 
would be required, but a geometrically acceptable presentation of the haptenic 
epitopes to surface Ig receptors would suffice to effect blockade.  In principle, 
this  mechanism would  allow  blockade  by  haptenated  polymers  other  than 
haptenated  polysaccharides,  as  long  as  the  critical  requirements of epitope 
presentation geometry were met (22). Our current data appear to be supportive 
of  either  mechanism  (c)  or  (d).  If mechanism  (d)  is  operative,  then  the 
requirements for critical epitope presentation can be about equally well met by 
either  linear  or  multi-branched  haptenated  polysaccharide blocking  agents 
(Fig. 1). 
The joint signal provided by hapten-conjugated carrier could be either passive 
or active in nature.  It is conceivable that the multiple site interaction which 
occurs between Ig receptors and multivalent haptenated Ficoll prevents disso- 
ciation  of hapten  from  these  Ig  receptors,  and  thereby  assures  saturative 
2 Although current findings provide no support for these first two alternatives, final consider- 
ation of these possibilities is being temporarily held in abeyance since higher test concentrations 
of free hapten and/or free carrier can be attained in in vitro or cell transfer systems. 
3 Two sets of authors have recently reported the absence of unique differentiation antigens on 
spleen cells from CBA/N and/or hybrid male mice (25, 26). To the best of our knowledge, there are 
no reports claiming the presence of any additional unique antigens or receptors on lymphocytes 
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preemption of most available receptors. Such a blockade mechanism would be 
passive in nature and would not necessarily require metabolic changes in the 
cell.  At present, no adequate explanation can be offered for why cell capping 
and consequent shedding of antigen-antibody complexes would not provide for 
an early escape of B cells from such hapten-specific blockade. 
The marked effectiveness of X-linked hapten-polysaccharide-mediated  block- 
ade,  even at extremely low dosage levels (Fig.  1),  seems consistent with an 
active role for haptenated polysaccharide blocking agents. In this instance, the 
joint  signal  provided  by  haptenated  polysaccharide would  produce  distinct 
metabolic changes in the B cell. These changes would make the B cell refractory 
to subsequent thymic-dependent signals for secretory activation.  Presumably 
refractoriness to secretory activation would not preclude memory  cell activation. 
A related concept has recently been proposed to account for B-cell activation 
in normal mice (22). According to this concept, an activation signal for normal 
B cells can be accomplished by the formation of"immunons" at B-cell surfaces. 
An "immunon" is  formed when ~12-16  Ig receptors are  linked together by 
antigen in a spatially continuous cluster which can contribute to an activation 
signal. The number of geometrically stable "immunons" which must be formed 
on any given B-cell surface in order to cause its activation is unknown. Since 
many thymic-independent antigens are intrinsically nonmitogenic (5), and are 
thus presumably incapable of delivering an ordinary mitogenic second signal, 
the "immunon" concept is especially attractive. 
The  currently advanced alternative  (which might  apply  only to  defective 
CBA/N mice) requires only that a similar geometrically stable arrangement of 
cell surface Ig might be generated by haptenated polysaccharide agents. These 
blocking  agents  would  then  actively lead  to  a  refractory B-cell  state.  For 
convenience, such a critical arrangement of cell surface Ig receptors might be 
termed a "toleron." Conceivably, the generally increased density of Ig surface 
receptors  on  the  B  cells  of CBA/N  mice  (6)  might  predispose  to  "toleron" 
development. 
Refractoriness of B Memory Cells to Hapten-Polysaccharide.Mediated Block- 
ade.  Although CBAJN  mice appear to be delinquent in the development of 
mature IgM  to  IgD-type cell  surface receptor relationships  (7,  8,  23), prior 
immunization with a thymic-dependent antigen generates specific  B memory 
cell  populations.  This  maturational  change  is  accompanied,  no  doubt,  by 
marked changes in the representation and density of surface Ig receptors on the 
specifically affected B-cell clones (11, 12). Thus, some responding B cells may 
escape their usual prolonged infancy. These memory cells are apparently no 
longer  susceptible  to  haptenated polysaccharide-induced blockade,  but  they 
have still  not acquired any appreciable capacity for direct responsiveness to 
haptenated polysaccharide antigens  (Table  V).  Why changes in  Ig receptor 
density could lead to escape from susceptibility to blockade without recovery of 
some capacity for direct responses to polysaccharide antigens cannot be readily 
explained. One possibility is that circulating antibody generated at the time of 
memory cell induction with DNP~2-KLH could effectively  intercept and neutral- 
ize  the  blockading capacity of DNP59,Ficoll.  In this  case,  the  memory cells 
would not actually be  subjected to blockade, and their failure to respond to B.  MERCHANT,  H.  SNIPPE, E.  F.  LIZZIO, AND  J.  K.  INMAN  1767 
challenge  with  DNPs~-Ficoll would simply  represent  maintenance  of their 
innate unresponsiveness to that antigen. 
The early observations of Baker et al.  (24) extended by Schrader and Nossal 
(13) have demonstrated that even "end-stage" secretory B cells are susceptible 
to external  stimuli imposed by surface-bound antigens.  This phenomenon has 
been termed effector cell blockade, and Schrader has recently shown (14) that it 
is accomplished  by multipoint interactions with Ig receptors. He has also shown 
that specific  enzymatic interruption of  such Ig linkages results in the reversibil- 
ity of  the delivered signal. The work of Klaus has emphasized that B precursor 
cells of normal  mice are  also susceptible (at  quite  high dosages) to  specific 
hapten-polysaccharide-imposed blockade (10-12). Thus, it seems reasonable to 
assume that B precursors as well as B secretory cells might well be susceptible 
to Ig receptor-mediated cell surface stimuli. 
The  fact that those conditions optimal  for secretory B-cell blockade  failed 
almost completely to cause B memory  cell blockade indicates that some signal 
from the thymic-dependent DNP~2-KLH is reaching at least some B cells. It is 
difficult to imagine that such near total  escape from blockade could occur if 
blockade is routinely  accomplished by a  metabolically active but reversible 
switching event on B precursor cells. This argument  seems especially cogent 
since memory  cell formation was virtually complete when tested at 8 days post- 
blockade  (Table VIII), but  secretory cell detection was  still  minimal when 
primary  DNP~2-KLH stimulation  was given as  late  as  14  days after  DNP59- 
Ficoll  injection (Fig. 2).  At  present  it  is  not  possible to  tell  whether  the 
precursors for secretory and for memory B cells represent two distinct subpopu- 
lations in CBA/N mice, or whether there is actually only one targeted precursor 
population.  If a  single precursor  population  is  involved, then  the  signal 
requirements  for immunogen-triggered differentiation into memory cells must 
be  minimal  as  compared to  those  required  for maturation  into  immediate 
secretory function. In any case, memory  cell formation in these B-cell defective 
mice must clearly escape blockade more readily than  secretory cell activation. 
The  Significance  of  Hapten-Polysaccharide-Mediated  Selective  Immune 
Blockade.  The  present  study emphasizes  the  importance  of Ig receptors for 
induction  of specific hapten-polysaccharide-mediated  B-cell blockade in defec- 
tive  CBA/N  mice.  It  has  disclosed  the  refractoriness  of B  memory  cells  to 
blockade, and the inevitability of memory cell development despite the presence 
of profound secretory cell blockade. It also raises many questions among which 
are: (a)  is blockade strictly and exclusively a  B-cell function? (b) does blockade 
represent merely a  passive saturation of surface Ig receptors on B cells? (c) is 
participation of a second category of non-Ig receptors necessary for transmission 
of the  blockade  signal?  (d)  is  the  signal  for  blockade  on  any  given  B  cell 
reversible? (e) can memory cell formation proceed in the presence of a complete 
and sustained secretory B-cell blockade? and finally, (D to what extent do the 
cellular and molecular events which lead to the X-linked blockade of CBA/N B 
cells  resemble  the  events  which  cause  hapten-specific  blockade  of normal  B 
cells? Clear answers to any of the first five questions will be distinctly useful, 
but  a  definitive  answer  to  the  final  question  could  ultimately  be  of major 
importance in efforts to control detrimental B-cell responses. 1768  HAPTEN-SPECIFIC,  B-CELL BLOCKADE IN  CBA/N MICE 
Summary 
CBA/N mice, a mutant CBA subline, harbor an X-linked B-cell defect which 
prevents them from mounting immune responses to certain thymic-independent 
antigens such as pneumococcal polysaccharides and haptenated-Ficoll deriva- 
tives.  These  mice  and  the  hybrid male  progeny of CBAJN  females  are  also 
exquisitely sensitive to a  hapten-specific blockade of their otherwise adequate 
immune  responses to  thymic-dependent antigens  such  as N-2,4-dinitrophen- 
ylated-hemocyanin (DNP-KLH).  As little as  10 ng of a  DNP-Ficoll conjugate 
given 2 h  before immunization with a  5,000-fold greater dosage of DNP-KLH, 
virtually  abolishes  the  4th-day  direct  plaque-forming  cell  (PFC)  response 
specific for DNP.  Responding hybrid  (CBA/N  ×  C3H/HeN) female mice  are 
resistant to such blockade even at DNP-Ficoll dosages increased by three orders 
of magnitude.  The DNP hapten and Ficoll must be chemically joined for this 
blocking  effect to  occur,  and  increasing  the  hapten  derivatization  of FicoU 
increases its blockade-invoking capacity. Significant blockade can be produced 
by administering DNP-Ficoll as early as 4 days before or as late as 4 h  after 
immunization  with  DNP-KLH.  All  currently  available  data  point  to  the 
defective B cell as the target of this hapten-polysaccharide-mediated blockade. 
Mice bearing  B  memory cells,  however,  are  refractory to such  blockade.  In 
addition, DNP-Ficoll injections which cause virtually total blockade of 4th-day 
primary  direct  PFC  responses  to  DNP-KLH have  little  or  no  effect on  the 
development of DNP-reactive B-cell memory measured at either 8 or 30 days. 
These  findings suggest  very different blockade susceptibilities for B  cells or 
their precursors at various stages of differentiative development. Our findings 
also lead to the formulation of testable hypotheses regarding the mechanism of 
this selective B-cell blockade phenomenon. 
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